US Patent Issued to THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE on May 26 for "Methods, oligonucleotides, and kits for detection and treatment of coronavirus" (Arizona Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,725, issued on May 26, was assigned to THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE (Phoenix).

"Methods, oligonucleotides, and kits for detection and treatment of coronavirus" was invented by Puiyee Agnes Chan (Phoenix), Nicholas J. Schork (Phoenix) and Yongwook Choi (Phoenix).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, kits, and oligonucleotides used in the detection of coronavirus, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are disclosed. In some aspects, the oligonucleotides are primers or probes used in the described methods or kits. The nucleotide sequence of the oligonucleotide consists of 300 or less, 1...